173 related articles for article (PubMed ID: 38106820)
21. Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19.
Dallalzadeh LO; Ozzello DJ; Liu CY; Kikkawa DO; Korn BS
Orbit; 2022 Oct; 41(5):616-619. PubMed ID: 33752571
[TBL] [Abstract][Full Text] [Related]
22. Evaluation and Comparison of Mucormycosis Patients' Features Undergoing Functional Endoscopic Sinus Surgery Prior to and during the COVID-19 Pandemic: A Case-Control Study.
Dehghanpisheh L; Eghbal M; Salari M; Shahriarirad R; Borzou N; Vatankhah P
Int J Clin Pract; 2022; 2022():1248325. PubMed ID: 35693548
[TBL] [Abstract][Full Text] [Related]
23. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
[TBL] [Abstract][Full Text] [Related]
24. Rhino-orbito-cerebral mucormycosis during Covid-19 pandemic- a prospective observational study.
Fatima N; Ahmed S; Shameem M; Ahmed A; Hasan W; Khan PA
Indian J Med Microbiol; 2023; 46():100467. PubMed ID: 37651764
[TBL] [Abstract][Full Text] [Related]
25. Diabetes mellitus and other underlying conditions in patients with coronavirus disease 2019 associated rhino-orbito-cerebral mucormycosis: a systematic review and meta-analysis.
Zobairy H; Salem MM; Ghajarzadeh M; Mirmosayyeb O; Mirsalehi M
J Laryngol Otol; 2022 Sep; 136(9):788-798. PubMed ID: 35514092
[TBL] [Abstract][Full Text] [Related]
26. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
[TBL] [Abstract][Full Text] [Related]
28. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
[No Abstract] [Full Text] [Related]
29. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
[TBL] [Abstract][Full Text] [Related]
30. Spotlight on the Mucormycosis Outbreak: A Deadly Fungal Infection That Followed the COVID-19 Pandemic.
Patel SN; Shah S; Panchal J; Desai C; Upadhya IB; Patel M
Cureus; 2023 Feb; 15(2):e35095. PubMed ID: 36938207
[TBL] [Abstract][Full Text] [Related]
31. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
Kumar S; Kumar H; Mali M; Meena BL
Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.
Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P
Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
[TBL] [Abstract][Full Text] [Related]
34. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
35. Mucormycosis in pre-COVID-19 and COVID-19 era: A study of prevalence, risk factors and clinical features.
Arjmand P; Bahrami M; Mohammadie ZE; Taherynejad M; Khorasani NY; Mehrad-Majd H; Roshanzamir I; Bakhshaee M
Laryngoscope Investig Otolaryngol; 2022 Sep; 7(5):1343-50. PubMed ID: 36249085
[TBL] [Abstract][Full Text] [Related]
36. Cross-sectional study to describe the severity, bio-chemical associations, and final outcomes of COVID-19-associated rhino-orbital-cerebral mucormycosis in a tertiary hospital of East India.
Kumari A; Ranjan A; Nishant P; Sinha S; Sinha RK
Indian J Ophthalmol; 2023 May; 71(5):2193-2198. PubMed ID: 37202947
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 Associated Mucormycosis with Newly Diagnosed Diabetes Mellitus in Young Males - A Tertiary Care Experience.
Kapoor S; Saidha PK; Gupta A; Saini U; Satya S
Int Arch Otorhinolaryngol; 2022 Jul; 26(3):e470-e477. PubMed ID: 35846801
[No Abstract] [Full Text] [Related]
38. Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.
Pakdel F; Ahmadikia K; Salehi M; Tabari A; Jafari R; Mehrparvar G; Rezaie Y; Rajaeih S; Alijani N; Barac A; Abdollahi A; Khodavaisy S
Mycoses; 2021 Oct; 64(10):1238-1252. PubMed ID: 34096653
[TBL] [Abstract][Full Text] [Related]
39. COVID-19 and mucormycosis superinfection: the perfect storm.
Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors of Rhino Orbital Mucormycosis.
Patade Y; G R
Cureus; 2022 Dec; 14(12):e33145. PubMed ID: 36721573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
